[1]. Robot-assisted radical nephrectomy and inferior vena cava tumor thrombectomy using the novel surgical robot platform, hinotori: Initial experience with two cases.
IJU case reports [Volume]7 [Issue]2 [Page]96 -99 （2024/） [Reviewed] Yes
[DOI] [2]. Relationship Between Adverse Events and Progression-free Survival in Patients Receiving Cabozantinib for Previously Treated Metastatic Renal Cell Carcinoma.
Anticancer research [Volume]44 [Issue]2 [Page]781 -786 （2024/） [Reviewed] Yes
[DOI] [3]. Robot-assisted radical nephroureterectomy for upper urinary tract tumor: initial experience with the use of novel surgical robot system, hinotori.
Translational cancer research [Volume]12 [Issue]12 [Page]3522 -3529 （2023/） [Reviewed] Yes
[DOI] [4]. Robot-assisted radical nephrectomy using novel surgical robot platform, hinotori: Report of initial series of 13 cases.
International journal of urology : official journal of the Japanese Urological Association [Volume]30 [Issue]12 [Page]1175 -1179 （2023/） [Reviewed] Yes
[DOI] [5]. Efficacy and safety of axitinib for metastatic renal cell carcinoma: Real-world data on patients with renal impairment.
Urologic oncology [Volume]41 [Issue]11 [Page]458.e9 -458.e19 （2023/） [Reviewed] Yes
[DOI]